STUDY OF EFFECT OF AN AYURVEDIC DRUG IN PATIENTS WITH DIABETIC NEPHROPATHY

STUDY OF SHOTHA CHIKITSA SIDDHANTA WITH SPECIAL REFERENCE TO DIABETIC NEPHROPATHY

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020205

Enrollment

100

Registered

2019-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E082- Diabetes mellitus due to underlying condition with kidney complications

Interventions

Intervention1: PUNARNAVA KASHAYA: IT IS KWATH MADE UP OF SINGLE DRUG PUNARNAVA ( BOERHAVIA DIFFUSA) Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: SUBJECTS WITH DIABETES MELLITUS HAVING PADASHOTHA

Exclusion criteria

Exclusion criteria: SUBJECTS WITH SHOTHA ON LEGS DUE TO OTHER DISEASES OTHERTHAN DIABETES MELLITUS SUBJECTS WITH HYPERTENSION , LIVER DISEASES, CARDIAC DISEASES ETC. PREGANANT AND LACTATING WOMEN SUBJECTS WITH TUBERCULOSIS , HIV ETC. INFECTIOUS DISEASES

Design outcomes

Primary

Measure	Time frame
TO REDUCE THE PADASHOTHATimepoint: 30 DAYS	—

Secondary

Measure	Time frame
INCREASE IN HB LEVELSTimepoint: 45 DAYS	—

Countries

India

Contacts

Public ContactDR SANDEEP DESAI

AYURVEDA MAHAVIDYALAYA HUBBALLI

dr.vinu.vrh@gmail.com9916319007

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026